相似文献
1
[Say no to the extremes in the debate on lipid reduction].
Lakartidningen. 2011;108(36):1664-5.
2
[Target levels for LDL cholesterol are put out of the running. Cholesterol should be lowered maximally in high cardiovascular risk].
Lakartidningen. 2011;108(22-23):1240-3.
3
[Statin and absorption inhibitor work synergistically. More risk patient reach LDL cholesterol goal value].
MMW Fortschr Med. 2007 Apr 26;149(17):56-7.
4
Is intensive LDL-cholesterol lowering beneficial and safe?
Lancet. 2010 Nov 13;376(9753):1622-4. doi: 10.1016/S0140-6736(10)61545-0. Epub 2010 Nov 8.
5
Improve-it: Full disclosures?
Int J Cardiol. 2015 Dec 15;201:380-1. doi: 10.1016/j.ijcard.2015.08.093. Epub 2015 Aug 10.
6
[Strengthened support for statin therapy as secondary prevention. Doubtful evidence for more intensive lowering of cholesterol levels].
Lakartidningen. 2011;108(22-23):1234-5.
7
[Statins plus cholesterol resorption inhibitor. LDL goal values attainable].
MMW Fortschr Med. 2002 Sep 19;144(38):56.
8
[SBU should investigate what is an evidence-based and cost-effective use of statins].
Lakartidningen. 2009;106(32-33):1992-4.
9
[Controlling LDL cholesterol from 2 sides. "I have never seen such low LDL values"].
MMW Fortschr Med. 2003 May 15;145(20):59.
10
[Sequelae of the CARDS Study. LDL of 110 mg/dl still too high?].
MMW Fortschr Med. 2004 Jun 24;146(26):14.
Zotero 插件